GLP-1 Medications Show Medical Cost Benefits, With Adherence and Women’s Health as Key Factors

Share!

Risk & Insurance - Jan 19, 2026

Aon study shows slower medical cost growth for GLP-1 users, yet employers face complex decisions on coverage amid evolving pricing, health patterns. The post GLP-1 Medications Show Medical Cost Benefits, With Adherence and Women’s Health as Key Factors appeared first on Risk & Insurance. ...

Read Full Article

Recommended Articles

Slow Hiring Amid Resilient GDP Creates Mixed Signals for Workers’ Compensation in 2026

Posted: Mar 30, 2026

The U.S. economy grew at a 2.0% pace in 2025, but the labor market experienced its weakest job growt...

AI Tops Insurance Executive Priorities as Regulatory Concerns and Market Volatility Reshape the Risk Landscape

Posted: Mar 30, 2026

AI has become the top priority for insurance industry leaders heading into 2026, according to the In...

The AI Confidence Gap: Why Workers’ Compensation Leaders Need Better Governance Before Deployment

Posted: Mar 29, 2026

Misunderstanding artificial intelligence (AI) could put organizations and patients at risk. Here's w...